News & Updates

Early treatment with sodium-glucose cotransporter 2 inhibitors (SGLT2i) is associated with a lower cardiovascular risk among diabetes patients with acute myocardial infarction (MI), reports a study.

Combining toripalimab with gemcitabine and cisplatin chemotherapy is safe and efficacious in patients with muscle-invasive bladder cancer (MIBC), demonstrating its potential as a neoadjuvant treatment (NAT) in a phase II clinical trial.

Higher luteinizing hormone (LH) at baseline and a history of prior androgen-deprivation therapy (ADT) are associated with worse response to clomiphene citrate (CC) therapy in men with low testosterone, a study has shown.

Treatment with oral glucocorticoids may contribute to elevated risks of adverse psychiatric outcomes, including the onset and relapse of common psychiatric disorders, as shown in a population-based cohort study.

Users of combined oral contraceptives (COCs) are at increased risk of emotional eating, as reported in a study.

An antimicrobial stewardship intervention to reduce the use of piperacillin–tazobactam in children with acute appendicitis has been shown to result in improved clinical outcomes.

Once-daily treatment with the highest orforglipron dose is associated with significant reductions in body weight and waist circumference at week 72 in women with obesity or overweight, regardless of menopausal status, according to a post hoc analysis of the phase III ATTAIN-1 and -2 trials presented at ADA 2026.

The oral Janus kinase (JAK) inhibitor baricitinib has demonstrated efficacy in inducing and maintaining glucocorticoid-free remission in patients with early polymyalgia rheumatica, according to the phase 3 JAK-Spare trial.

Administration of terlipressin as either continuous or bolus infusion results in similar length of hospital stay, packed cell volume, rebleeding, and mortality rates in patients with acute variceal haemorrhage, a recent study has shown.